Literature DB >> 9229573

NSAIDs, gastrointestinal injury, and cytoprotection.

J M Scheiman1.   

Abstract

Gastrointestinal toxicity caused by nonsteroidal anti-inflammatory drugs (NSAIDs) is the most frequent drug side effect in the United States. NSAIDs are implicated in the development of complicated peptic ulcer disease and injury to the small bowel and colon. NSAIDs interfere with prostaglandin-mediated epithelial defense mechanisms and also cause direct epithelial toxicity. Current and future approaches to the prevention and management of NSAID injury are reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9229573     DOI: 10.1016/s0889-8553(05)70247-8

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  29 in total

1.  Can we make any recommendations about physical activity and peptic ulcer disease?

Authors:  E Strom
Journal:  West J Med       Date:  2000-08

2.  Preventing NSAID Toxicity to the Upper Gastrointestinal Tract.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

Review 3.  Aspirin use and potential mechanisms for colorectal cancer prevention.

Authors:  C S Williams; W Smalley; R N DuBois
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Cyclooxygenase 2 inhibitors and colon cancer.

Authors:  Ana Maria Gonzalez-Angulo; Jyotsna Fuloria; Om Prakash
Journal:  Ochsner J       Date:  2002

5.  Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.

Authors:  Manouche Tavakoli
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism.

Authors:  Jacinda J Power; Miranda S Dennis; Maria J Redlak; Thomas A Miller
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion.

Authors:  D C Devor; B D Schultz
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 8.  Epithelial restitution and wound healing in inflammatory bowel disease.

Authors:  Andreas Sturm; Axel U Dignass
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 9.  Balancing the gastrointestinal benefits and risks of nonselective NSAIDs.

Authors:  David A Peura; Lawrence Goldkind
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

Review 10.  Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.

Authors:  James M Scheiman; A Mark Fendrick
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.